FDA Advises of Serious Risks Associated with Off-Label Use of Quinine
Published: Sep 10, 2012
The U.S. Food and Drug Administration (FDA) recently posted an article of interest for health care professionals on their website about the serious risk of off-label use of Quinine for the treatment or prevention of leg cramps. The FDA estimates that ninety-two percent of quinine use is off-label for indications such as leg cramps and muscle pain.
According to the FDA, Quinine is FDA-approved for the treatment of uncomplicated Plasmodium falciparum malaria. Quinine is associated with serious and life-threatening adverse events, including:
Want to read the full alert and receive alert emails?
